Sanofi-Aventis SA lost more than €2 billion of sales due to generic competition in 2010. This, plus healthcare reform and government austerity, contributed to a 0.8% decline in group sales, at constant exchange rates, in 2010. ---Subscribe to MedNous to access this article--- Company News
